Novavax
NVAX
#5550
Rank
A$1.87 B
Marketcap
A$11.50
Share price
0.86%
Change (1 day)
3.80%
Change (1 year)

Novavax (NVAX) Fails to deliver data

Key failure to deliver metrics for Novavax:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Novavax (NVAX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Novavax (NVAX) - since 2019

Volume in USD (price x number of shares), data since 2019

Novavax (NVAX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026A$10.85 M-82.56%
2025A$62.26 M-58.47%
2024A$0.14 B-61.61%
2023A$0.39 B-2.97%
2022A$0.40 B0.26%
2021A$0.40 B22.77%
2020A$0.32 B531.98%
2019A$51.73 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Novartis
NVS
A$0.27 BA$0.36 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$23.8 MA$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$45.44 MA$0.17 B๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$18.15 MA$0.23 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$4.14 MA$23.87 M๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$1.57 MA$11.14 M๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$0.62 MA$4.42 M๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
A$0.01 MA$4.06 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$3.95 MA$8.45 M๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 MA$3.64 M๐Ÿ‡บ๐Ÿ‡ธ USA